Skip to main content
Year archive

ArcticZymes Technologies — 2017 filings

All 80 regulatory filings released by ArcticZymes Technologies (AZT) in 2017, sourced directly from the official regulator.

80 Filings
2017 Period
2017 filings (80)
Filing Released Lang
ArcticZymes launches two new polymerase enzymes
Regulatory Filings
2017-12-20 English
ArcticZymes launches two new polymerase enzymes
Regulatory Filings
2017-12-20 English
Financial calendar
Report Publication Announcement
2017-11-29 English
Biotec: Attachment to the Q2 2017 report
Report Publication Announcement
2017-10-30 English
Biotec: Attachment to the Q2 2017 report
Report Publication Announcement
2017-10-30 English
Mandatory notification of trade
Director's Dealing
2017-10-24 English
Woulgan® to be listed on UK Drug Tariff
Regulatory Filings
2017-10-19 English
Woulgan® to be listed on UK Drug Tariff
Regulatory Filings
2017-10-19 English
Biotec Pharmacon: Results for Q3 2017
Earnings Release Q3 2017
2017-10-19 English
Biotec Pharmacon: Q3 2017 Presentation
Interim / Quarterly Report Q3 2017
2017-10-19 English
Biotec Pharmacon: Q3 2017 Presentation
Report Publication Announcement
2017-10-19 English
Biotec Pharmacon ASA: Invitation to presentation of Q3 2017 reults
Report Publication Announcement
2017-10-13 English
ArcticZymes new product launch to serve the bio-manufacturing market segment
Regulatory Filings
2017-09-29 English
ArcticZymes new product launch to serve the bio-manufacturing market segment
Regulatory Filings
2017-09-29 English
Biotec has entered into a supply agreement for M-Glucan to the pet sector
Regulatory Filings
2017-09-25 English
Biotec has entered into a supply agreement for M-Glucan to the pet sector
Regulatory Filings
2017-09-25 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2017-09-14 English
Biotec Pharmacon appoints new CEO
Board/Management Information
2017-09-12 English
Biotec Pharmacon appoints new CEO
Board/Management Information
2017-09-12 English
Woulgan® application to be reconsidered by UK Drug Tariff
Regulatory Filings
2017-09-12 English
Woulgan® application to be reconsidered by UK Drug Tariff
Legal Proceedings Report
2017-09-12 English
Biotec Pharmacon - resignation of board member
Board/Management Information
2017-09-06 English
Mandatory notification of trade
Director's Dealing
2017-08-31 English
Mandatory notification of trade
Director's Dealing
2017-08-30 English
Biotec has prolonged supply agreement for delivery of M-Glucan
Regulatory Filings
2017-08-29 English
Biotec has prolonged supply agreement for delivery of M-Glucan
Regulatory Filings
2017-08-29 English
Biotec has entered into a supply agreement for M-Gard® in the USA
M&A Activity
2017-08-25 English
Biotec has entered into a supply agreement for M-Gard® in the USA
Regulatory Filings
2017-08-25 English
Biotec Pharmacon: Capital Markets Day 2017
Report Publication Announcement
2017-08-17 English
Biotec Pharmacon: Capital Markets Day 2017
Investor Presentation
2017-08-17 English
Biotec Pharmacon: Capital Markets Day 2017
Report Publication Announcement
2017-08-17 English
Biotec Pharmacon: Q2 2017 Results and presentation
Report Publication Announcement
2017-08-17 English
Extended distribution agreement with Rogg Verbandstoffe in Germany
M&A Activity
2017-07-18 English
Extended distribution agreement with Rogg Verbandstoffe in Germany
Regulatory Filings
2017-07-18 English
Biotec Pharmacon ASA: Invitation to Q2 2017 presentation and Capital Markets Day
Investor Presentation
2017-07-06 English
Biotec Pharmacon ASA: Invitation to Q2 2017 presentation and Capital Markets Day
Investor Presentation
2017-07-06 English
Correction - Annual report 2016
Annual Report FY 2016
2017-06-30 English
Correction - Annual report 2016
Report Publication Announcement
2017-06-30 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2017-06-26 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2017-06-02 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2017-06-02 English
Biotec Pharmacon will present at Anglonordic Life Science Conference
Investor Presentation
2017-05-31 English
Biotec Pharmacon will present at Anglonordic Life Science Conference
Report Publication Announcement
2017-05-31 English
Biotec appeals UK Drug Tariff rejection
Legal Proceedings Report
2017-05-19 English
Biotec appeals UK Drug Tariff rejection
Legal Proceedings Report
2017-05-19 English
Biotec Pharmacon - Minutes from Annual General Meeting
AGM Information
2017-05-11 English
Biotec Pharmacon - Minutes from Annual General Meeting
AGM Information
2017-05-11 English
Biotec Pharmacon ASA presentation at Annual General Meeting
AGM Information
2017-05-11 English
Biotec Pharmacon ASA presentation at Annual General Meeting
AGM Information
2017-05-11 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2017-05-08 English
BIOTEC Flaggemelding
AGM Information
2017-05-05 Norwegian
Patent on technology platform SBG granted Biotec Pharmacon in the US
Regulatory Filings
2017-05-04 English
Patent on technology platform SBG granted Biotec Pharmacon in the US
Regulatory Filings
2017-05-04 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2017-05-03 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2017-05-03 English
UK Drug Tariff rejects current Woulgan application
Regulatory Filings
2017-05-02 English
UK Drug Tariff rejects current Woulgan application
Regulatory Filings
2017-05-02 English
Biotec Pharmacon: Results for Q1 2017
Earnings Release Q1 2017
2017-04-27 Norwegian
Biotec Pharmacon: Results for Q1 2017
Interim / Quarterly Report Q1 2017
2017-04-27 Norwegian
Biotec Pharmacon: Q1 2017 Presentation
Investor Presentation
2017-04-27 English
Biotec Pharmacon: Results for Q1 2017
Earnings Release Q1 2017
2017-04-27 English
Biotec Pharmacon: Q1 2017 Presentation
Report Publication Announcement
2017-04-27 English
Biotec Pharmacon: Resultater for Q1 2017
Report Publication Announcement Q1 2017
2017-04-27 Norwegian
Biotec Pharmacon: Resultater for Q1 2017
Report Publication Announcement Q1 2017
2017-04-27 Norwegian
Biotec Pharmacon ASA: Invitation to presentation of Q1 2017 results
Report Publication Announcement
2017-04-21 English
Biotec Pharmacon ASA: Notice of ordinary general meeting
AGM Information
2017-04-20 English
Biotec Pharmacon ASA: Notice of ordinary general meeting
AGM Information
2017-04-20 English
Biotec Pharmacon ASA - Annual report 2016
Annual Report FY 2016
2017-04-20 Norwegian
Biotec Pharmacon ASA - Annual report 2016
Report Publication Announcement
2017-04-20 English
Woulgan® Gel registered as a Class 1 exempt by the FDA in the USA
Regulatory Filings
2017-03-28 English
Woulgan® Gel registered as a Class 1 exempt by the FDA in the USA
Regulatory Filings
2017-03-28 English
Biotec Pharmacon's CEO, Svein W. F. Lien resigns due to health issues
Board/Management Information
2017-03-16 English
Biotec Pharmacon's CEO, Svein W. F. Lien resigns due to health issues
Board/Management Information
2017-03-16 English
Biotec Pharmacon: Results for Q4 2016
Earnings Release Q4 2016
2017-02-02 English
Biotec Pharmacon: Q4 2016 Presentation
Investor Presentation
2017-02-02 English
Biotec Pharmacon: Q4 2016 Resultater
Earnings Release Q4 2016
2017-02-02 Norwegian
Biotec Pharmacon: Q4 2016 Presentation
Report Publication Announcement
2017-02-02 English
Biotec Pharmacon: Q4 2016 Resultater
Earnings Release Q4 2016
2017-02-02 Norwegian
Biotec Pharmacon ASA: Invitation to presentation of Q4 2016 results
Report Publication Announcement
2017-01-25 English
Biotec Pharmacon ASA: Invitation to presentation of Q4 2016 results
Report Publication Announcement
2017-01-25 English